National Cancer Institute; Notice of Closed Meetings, 29725 [2015-12542]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 99 / Friday, May 22, 2015 / Notices
extension acted with due diligence
during the regulatory review period by
November 18, 2015. To meet its burden,
the petition must contain sufficient facts
to merit an FDA investigation. (See H.
Rept. 857, part 1, 98th Cong., 2d sess.,
pp. 41–42, 1984.) Petitions should be in
the format specified in 21 CFR 10.30.
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) electronic or written
comments and written or electronic
petitions. It is only necessary to send
one set of comments. Identify comments
with the docket number found in
brackets in the heading of this
document. If you submit a written
petition, two copies are required. A
petition submitted electronically must
be submitted to https://
www.regulations.gov, Docket No. FDA–
2013–S–0610. Comments and petitions
that have not been made publicly
available on https://www.regulations.gov
may be viewed in the Division of
Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Comments and petitions that have not
been made publicly available on
https://www.regulations.gov may be
viewed in the Division of Dockets
Management between 9 a.m. and 4 p.m.,
Monday through Friday.
Dated: May 18, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015–12397 Filed 5–21–15; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
asabaliauskas on DSK5VPTVN1PROD with NOTICES
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications/
contract proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications/
contract proposals, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
VerDate Sep<11>2014
18:19 May 21, 2015
Jkt 235001
Name of Committee: National Cancer
Institute Special Emphasis Panel; Peptide
Reagents for Proteomics.
Date: June 15, 2015.
Time: 11:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
5W030, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Thomas M. Vollberg,
Ph.D., Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W102, Rockville, MD 20850,
240–276–6341, vollbert@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Mobile
Health Monitoring Devices.
Date: June 16, 2015.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
2E030, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Thomas M. Vollberg,
Ph.D., Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W102, Rockville, MD 20850,
240–276–6341, vollbert@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Wound
Healing Materials.
Date: June 17, 2015.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
4E030, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Thomas M. Vollberg,
Ph.D., Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W102, Rockville, MD 20850,
240–276–6341, vollbert@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; R13
Conference Grant Review.
Date: June 23, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W556, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Bratin K. Saha, Ph.D.,
Scientific Review Officer, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W556, Rockville, MD 20850, 240–
276–6411, sahab@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Opportunities for Collaborative Research at
the NIH Clinical Center (U01).
PO 00000
Frm 00124
Fmt 4703
Sfmt 4703
29725
Date: July 22, 2015.
Time: 9:00 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
2E908, Rockville, MD 20850.
Contact Person: Caron A. Lyman, Ph.D.,
Chief, Scientific Review Officer, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W126, Bethesda, MD 20892, 240–
276–6348, lymanc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 19, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–12542 Filed 5–21–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Advisory Committee to the Director,
National Institutes of Health.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Advisory Committee
to the Director, National Institutes of Health.
Date: June 11–12, 2015.
Time: June 11, 2015, 8:30 a.m. to 6:00 p.m.
Agenda: NIH Director’s Report, ACD
Working Group reports.
Place: National Institutes of Health,
Building 31, 6th Floor, Conference Room
6C6, 31 Center Drive, Bethesda, MD 20892.
Time: June 12, 2015, 8:00 a.m. to 2:00 p.m.
Agenda: NIH IC Director Reports and other
business of the committee.
Place: National Institutes of Health,
Building 31, 6th Floor, Conference Room
6C6, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
E:\FR\FM\22MYN1.SGM
22MYN1
]]>Agencies
[Federal Register Volume 80, Number 99 (Friday, May 22, 2015)]
[Notices]
[Page 29725]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-12542]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications/contract proposals and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications/contract
proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Peptide Reagents for Proteomics.
Date: June 15, 2015.
Time: 11:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 5W030, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Thomas M. Vollberg, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W102, Rockville, MD 20850, 240-276-6341,
vollbert@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Mobile Health Monitoring Devices.
Date: June 16, 2015.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 2E030, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Thomas M. Vollberg, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W102, Rockville, MD 20850, 240-276-6341,
vollbert@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Wound Healing Materials.
Date: June 17, 2015.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 4E030, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Thomas M. Vollberg, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W102, Rockville, MD 20850, 240-276-6341,
vollbert@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; R13 Conference Grant Review.
Date: June 23, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W556, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Bratin K. Saha, Ph.D., Scientific Review
Officer, Program Coordination and Referral Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W556, Rockville, MD 20850, 240-276-6411,
sahab@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Opportunities for Collaborative Research at the NIH Clinical
Center (U01).
Date: July 22, 2015.
Time: 9:00 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 2E908, Rockville, MD 20850.
Contact Person: Caron A. Lyman, Ph.D., Chief, Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W126, Bethesda, MD 20892, 240-276-6348,
lymanc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: May 19, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-12542 Filed 5-21-15; 8:45 am]
BILLING CODE 4140-01-P
